- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about MRNA
Recent news which mentions MRNA
Moderna's R&D Day Unveils Strategic Roadmap Beyond COVID Franchise: Goldman Sachs
September 14, 2023
From Benzinga
Why COVID Vaccine Demand Might Not Be That Strong
September 14, 2023
From Motley Fool
The 7 Best Meme Stocks to Buy Now: September 2023
September 14, 2023
From InvestorPlace
Five things to know about the new COVID-19 vaccine
September 13, 2023
From MarketWatch
Flu Vaccine Results Give Moderna (MRNA) Stock a Shot in the Arm
September 13, 2023
From InvestorPlace
Mainz Biomed Paves The Way For Early Colorectal Cancer Diagnosis And Even Prevention
September 13, 2023
From Benzinga
Europe Set To Launch Anti-Subsidy Probe Into Chinese EVs, American Airlines and Spirit Lower Profit Outlook, Manchester United's New Shirt Sponsor: Today's Top Stories
September 13, 2023
From Benzinga
Moderna, REV Group, Rocket Pharmaceuticals And Other Big Stocks Moving Higher On Wednesday
September 13, 2023
From Benzinga
Why Is Moderna Stock Trading Higher Today?
September 13, 2023
From Benzinga
Say Goodbye to Free COVID-19 Shots: CDC Approves Priced Boosters for Omicron Subvariants
September 13, 2023
From Benzinga
Moderna aims to prove it’s ‘more than a COVID company’
September 13, 2023
From MarketWatch
The 3 Most Undervalued Biotech Stocks to Buy in September 2023
September 12, 2023
From InvestorPlace
From MarketWatch
From Benzinga
Moderna, Pfizer Get FDA Nod For Omicron COVID Boosters While Novavax Waits
September 11, 2023
From Benzinga
New Pfizer and Moderna COVID shots approved by FDA
September 11, 2023
From MarketWatch
Longeveron (NASDAQ: LGVN) Reports 100% 5-Year Survival In Trial For Rare Pediatric Disease HLHS (Compared To 80% Survival In Historical Trials) To Market
September 11, 2023
From Benzinga
3 Meme Stocks That Could Actually Rebound in Q4
September 09, 2023
From InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
September 08, 2023
From Benzinga
COVID Vaccine Sales Are Declining. But Here's How They're Still Driving Growth at Moderna.
September 08, 2023
Tickers
MRNA
From Motley Fool
2 Nasdaq 100 Stocks That Are Surefire Buys in September and 1 to Avoid Like the Plague
September 08, 2023
From Motley Fool
7 Biotech Stocks to Sell in September Before They Crash & Burn
September 06, 2023
From InvestorPlace
From Benzinga
iPhone 15 May Face Hurdle In China, FTC Could Prosecute Amazon.com Over Antitrust Claims, United Airlines Planes Back In Air: Today's Top Stories
September 06, 2023
From Benzinga
Is Moderna's New Vaccine the Answer to the Highly Mutated BA.2.86 COVID-19 Variant?
September 06, 2023
Tickers
MRNA
From Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
September 05, 2023
From Benzinga
Cancer Remains Pharma's Biggest Challenge And Mainz Biomed Has The Tool To Help Win The Battle
September 05, 2023
From Benzinga
A Bull Trap Or More Gas In The Tank? Prepare For The Upcoming Week With MandoTrading!
September 05, 2023
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.